A Study of LY3361237 in Healthy Participants

NCT03695198 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3361237 - SC
DRUG: LY3361237 - IV
DRUG: Placebo - SC
DRUG: Placebo - IV

Sponsor

Eli Lilly and Company